Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Revenue (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Revenue for 3 consecutive years, with $1.0 million as the latest value for Q1 2022.

  • On a quarterly basis, Revenue fell 82.46% to $1.0 million in Q1 2022 year-over-year; TTM through Dec 2022 was $1.0 million, a 86.84% decrease, with the full-year FY2022 number at $1.0 million, down 86.84% from a year prior.
  • Revenue was $1.0 million for Q1 2022 at SELLAS Life Sciences, down from $1.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.7 million in Q1 2021 to a low of $1.0 million in Q1 2022.
  • A 3-year average of $2.6 million and a median of $1.9 million in 2020 define the central range for Revenue.
  • Biggest YoY gain for Revenue was 82.46% in 2022; the steepest drop was 82.46% in 2022.
  • SELLAS Life Sciences' Revenue stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then plummeted by 47.37% to $1.0 million in 2022.
  • Per Business Quant, the three most recent readings for SLS's Revenue are $1.0 million (Q1 2022), $1.9 million (Q2 2021), and $5.7 million (Q1 2021).